August 20, 2018 Bio/Pharma/CRO

China National Drug Administration grants rapid approval of Roche’s Alecensa (alectinib) as a treatment for ALK-positive lung cancer

Basel, 20 August 2018 China National Drug Administration grants rapid approval of Roche’s Alecensa (alectinib) as a treatment for ALK-positive lung cancer Approval follows priority review of Alecensa in China, just eight and nine months after EMA and FDA approvals, respectively Supporting data showed Alecensa significantly reduced the risk of disease progression or death by... Read more

August 17, 2018 Bio/Pharma/CRO Molecular Spectroscopy PR/Corporate

RedShiftBio Strengthens Focus on Applications with New Hire

AuthorBy B0ydR0nRSBPosted onAugust 17, 2018 Following the successful introduction of the AQS3TMpro, a protein characterization platform that allows users to ‘See Change in the secondary structure of proteins, the company is directing its focus to application development. Valerie Ivancic has joined the team as an Applications Scientist. She brings experience in the biophysical characterization of amyloid... Read more

August 15, 2018 Bio/Pharma/CRO PR/Corporate

Ubiquigent Awarded Innovate UK Grant, Closes Further Round of Investment and Strengthens Management Team

Dundee, UK, 15th August 2018: Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system targeted drug discovery, announced today that it was awarded a new grant from Innovate UK as part of its Investor Accelerator Pilot to support a project entitled; ‘The development of novel compounds to seed a neurodegeneration drug discovery programme’.... Read more

August 13, 2018 Bio/Pharma/CRO Life Science Tools Liq. Handling & Robotics Product Launch

Gyros Protein Technologies introduces Gyrolab CHO-HCP E3G Kit for impurity testing of biotherapeutics

Incorporates Cygnus Technologies’ gold standard reagents Ready-to-use immunoassay kit designed to increase productivity Uppsala, Sweden, 13 August 2018 Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls) – bioprocess workflow of biotherapeutics.... Read more

August 8, 2018 Bio/Pharma/CRO Chromatography Informatics & Software Lab Top-10

Agilent First to Release Software Supporting Standardized Data Format for Pharmaceutical Industry

Agilent First to Release Software Supporting Standardized Data Format for Pharmaceutical Industry SANTA CLARA, Calif., August 8, 2018 Agilent Technologies Inc. (NYSE: A) announced today the release of a new version of its chromatography data system that enables laboratories to export files in the Allotrope Data Format (ADF), an emerging standard developed by a consortium... Read more

August 1, 2018 Bio/Pharma/CRO Materials Analysis PR/Corporate

Robert Wicke Appointed as New CEO of Halo Labs

SAN FRANCISCO, Aug. 1, 2018 /PRNewswire/ — Halo Labs, a venture-backed scientific instrumentation company developing high-throughput biopharmaceutical quality control tools, today announced the appointment of Robert Wicke as Chief Executive Officer. Robert is a seasoned executive with over 25 years of experience growing successful life science instrumentation companies through the commercialization of innovative new products and inorganic growth. Prior to... Read more

July 30, 2018 Bio/Pharma/CRO Clinical Research/Diagn. M&A, Partnerships

Forbes Insights and IDEX Health & Science LLC Report Finds Life Science Sector is ‘Behind’ the Collaboration Curve

Rohnert Park, CA, July 30, 2018 — A survey of three technology-intensive industries has found a growing share of executives, including 68% of life science executives, see active and meaningful collaboration with their suppliers as essential to their future success/innovation/competitive advantage. 180 executives from the life science, pharmaceuticals, and aviation industries took part in the... Read more

July 26, 2018 Bio/Pharma/CRO Lab Top-10 M&A, Partnerships

MilliporeSigma and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology

News Release July 26, 2018 Your Contact: Karen Tiano +1 978 495 0093 Platform for creating sustained release formulations for virtually any class of biological API Eliminates pharmaceutical development hurdles MilliporeSigma’s global footprint makes InnoCore’s proprietary SynBiosys® drug delivery technology platform more widely available Burlington, Massachusetts, July 26, 2018 — MilliporeSigma and InnoCore Pharmaceuticals; Groningen, Netherlands, have... Read more

July 26, 2018 Bio/Pharma/CRO

Roche presents positive phase II results for the first-ever eye implant demonstrating sustained delivery of a biologic medicine to treat people with neovascular age-related macular degeneration

Basel, 26 July 2018 Roche presents positive phase II results for the first-ever eye implant demonstrating sustained delivery of a biologic medicine to treat people with neovascular age-related macular degeneration Roche’s investigational Port Delivery System with ranibizumab (PDS) is intended to reduce the burden of frequent eye injections for people with neovascular age-related macular degeneration... Read more

July 24, 2018 Bio/Pharma/CRO M&A, Partnerships

Pall Corporation and BioSciencesCorp Launch Strategic Partnership to Support Industry Drive Towards Integrated End-to-End Bioprocessing

PORT WASHINGTON, N.Y., July 24, 2018 /PRNewswire/ — Pall Corporation, a global leader in filtration, separation and purification, is partnering with BioSciencesCorp, a consulting company providing novel biologics and biosimilars process know-how and regulatory experience from molecule selection to full commercialization. Together they will deliver cost-effective manufacturing strategies, and efficient upstream and downstream process equipment and facility design... Read more